Handpicked Reviews of Contemporary Literature
The Rheumatologist: March 2008
Giant cell arteritis (GCA)—a type of vasculitis—is a group of diseases whose typical feature is inflammation of blood vessels. The blood vessels most commonly involved are the arteries of the scalp and head (especially the arteries over the temples), which is why another term for GCA is “temporal arteritis.” GCA can overlap with another rheumatic disease called polymyalgia rheumatica, and symptoms of the two conditions can occur at the same time or separately. The causes of GCA and polymyalgia rheumatica are unknown.
Over the past two years, we have heard presidential candidates touting their messages to voters. Each candidate has crafted messages they believe will appeal to voters, and as campaigns continue to accelerate, these messages will saturate the radio, television, and the reading materials of the American public.
March’s Coding Challenge
March’s Coding Answer
The professional relationship between partners in a joint medical practice is sometimes compared with a marriage. The partners must work under the same roof, share the same goals, and strive to make the practice as successful as it can be. Here are some tips for adding a new partner to your practice.
Five Within Our Reach science investigators provided overviews and updates of their RA research projects to the newly formed Within Our Reach advisory board at its inaugural meeting, held November 8, 2007.
The Affiliate Society Council (ASC), a subcommittee of the Committee on Rheumatologic Care, will replace the Regional Advisory Council as a support mechanism for the ACR when working with rheumatology programs at the local and national level. It launched in January. The ASC and the ACR will work in conjunction with state and local societies on practice advocacy issues and create best practices for information sharing.
When we focus on loss, do we hurt our chances for gain?
Help the REF lay foundations for our future
Low incidence makes research and diagnosis a challenge
Many innovative programs aim to meet the increasing need for pediatric rheumatologists
Our knowledge of OA has progressed far—does a cure lie ahead?